R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
more
Stories about Forschung
Grünenthal, Uniklinik RWTH Aachen and RTWH Aachen University collaborate to advance pain research
Aachen (ots) - Grünenthal, Uniklinik RWTH Aachen and RWTH Aachen University announced a collaboration to advance the development of next-generation pain medicines. The collaboration involves the institutes of Dr Angelika Lampert, Professor of Physiology at the Uniklinik RWTH Aachen and Dr Marc Spehr, ...
moreTechnische Universität München
New center for digital medicine and health
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37491 Images: https://mediatum.ub.tum.de/1663381 NEWS RELEASE Interdisciplinary research for the digital medicine of the future Federal and state governments approve funding for digital medicine and health center ...
moreNeuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
Dublin (ots/PRNewswire) - - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend ...
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
moreEuropean Inventor Award 2022: Meet the inventors that are shaping our world at virtual event
Munich (ots) - - The winners of the European Patent Office’s annual innovation prize will be revealed at a ceremony on 21 June 2022 at 12:00 CEST held in an all-new format - Discover the stories of 14 exceptional inventor teams and 4 young innovators from 14 countries - The public is now invited to vote for their favourite inventor to win the Popular Prize at ...
moreR-Biopharm announces test to detect monkeypox virus
moreDEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES
moreAbcam the most awarded company at 2022 industry awards
Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...
moreAbcam the most awarded company at 2022 industry awards
Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...
moreEFIC® and Grünenthal Announced Winners of Pain Research Grant 2022
Brussels/Aachen (ots) - - Five promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2022 - The E-G-G funds innovative research projects to advance understanding of pain, and improve the lives of people with pain The European Pain Federation EFIC® and the pharmaceutical company Grünenthal have announced the five recipients ...
moreHope Spot Ocean? – combining conservation and sustainable use / The new World Ocean Review: Communicating the latest marine knowledge understandably
moreNew therapeutic approach against SARS-CoV-2 successfully tested
Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...
moreGerman Research Offers Innovative Solutions to World’s Most Pressing Issues
Berlin (ots) - Germany renowned Fraunhofer Institutes have come up with novel approaches to everything from supply chains to digital medical care to agriculture. Europe’s largest economy is buoyed by an extraordinary number of extra-university research centers, as recent developments at one of the most prominent institutions – the Fraunhofer Society – show. There ...
moreKontrast Personalberatung GmbH
Global Research Institute with new Professorship in Tropical Medicine and Focus on Implementation Research
Hamburg (ots) - Institute assumes tasks of a WHO Collaborating Center (WHO-CC) Implementation Research - Kontrast Personalberatung assists in filling position The research institute from Hamburg will establish the department of implementation research and, with the new professorship of tropical medicine, set up a ...
moreZEISS Celebrates 175 Years of Innovation, Passion and the Courage to Develop
moreZentiva Advances Pharmaceutical Research Through ORBIS Project
Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...
moreEW Nutrition launches Ventar D, the next-generation gut health optimizer
Visbek (ots) - EW Nutrition announces the launch of a best-in-class next generation gut health modifier. Ventar D is an innovative proprietary blend of phytomolecules with a novel delivery mechanism. Ventar D addresses key requirements of the animal nutrition industry. The product has been formulated to support gut health and improve performance, resulting in an ...
moreDEBIOPHARM & DEXA MEDICA LAUNCH TRIPTORELIN COLLABORATION TO BRING NEW HOPE TO WOMEN WITH ENDOMETRIOSIS
Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...
moreSpaceIL is reaching out to Space organizations from all over the world to offer experiment proposals to Beresheet2 Lunar space mission
Tel Aviv, Israel (ots/PRNewswire) - Deadline for submission: November 15th, 2021 "Beresheet2" mission of the Israeli non-profit organization SpaceIL is expected to be launched in Q4/2024. This is an historic opportunity for a scientific and educational breakthrough that will reach the young generation. SpaceIL sent ...
moreDEBIOPHARM ENCOURAGES BREAKTHROUGH CANCER RESEARCH IN JAPAN THROUGH ITS COMPETITIVE JCA MAUVERNAY AWARD
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...
moreFirst participants enrolled in Clinical Trial with Nociceptin/Orphanin peptide receptor (NOP) agonist
Aachen (ots) - Today, Grünenthal announced that the first participants have been enrolled in a randomised, placebo- and active-controlled clinical trial for its peripherally restricted Nociceptin/Orphanin FQ peptide receptor (NOP) agonist. The compound is being developed to provide a non-opioid therapy option that ...
moreGreen Tech Cluster Styria GmbH
Hydrogen Research Map Austria: 18 Institutes and 1 Site - top in Europe
moreGrünenthal’s Glucocorticoid Receptor Modulator enters clinical development
Aachen (ots) - Grünenthal announced today that the first volunteers have been enrolled in a Phase I trial of its Glucocorticoid Receptor Modulator (GRM). The oral investigational medicine aims to provide a therapy option with broad anti-inflammatory efficacy and a more favourable benefit-risk profile compared to current glucocorticoid-based therapies like ...
moreAbcam opens new US facility in Boston, MA
Cambridge (ots/PRNewswire) - Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility is a central ...
moreCoronavirus: Commission launches the Coronavirus Global R&I Collaboration Portal
Brussels (ots) - At the European Research and Innovation Days today, the European Commission launched a new coronavirus collaboration portal that offers matchmaking opportunities for researchers and research projects worldwide focusing on the socio-economic aspects of the coronavirus pandemic. The initiative supports the ’Global Approach to Research and ...
moreDEBIOPHARM’S CD37 ANTIBODY DRUG CONJUGATE SHOWS PROMISING PHASE II RESULTS FOR THE TREATMENT OF B-CELL MALIGNANCIES
Lausanne, Switzerland (ots) - - Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin’s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease1 - Naratuximab ...
more- 2
Southeast Asia eCommerce platform Lazada launches public bug bounty program with YesWeHack
more BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June
Porto, Portugal (ots/PRNewswire) - The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the broad field of biomedicine. The winner will be chosen by an independent and ...
moreCAS launches new brand reflecting strategic evolution to empower smarter science
Columbus, Ohio (ots/PRNewswire) - Expanding portfolio of solutions and capabilities addressing growing need for curated scientific data and expertise to accelerate discovery CAS, a division of the American Chemical Society (ACS) that specializes in scientific information solutions, today launched a new brand reflecting the broadening scope of its solutions and ...
more
123456Next